‘Substantial’ Discount Helps Zolgensma Win Access In UK

 
• By Francesca Bruce

The English and Scottish health technology appraisal bodies NICE and the Scottish Medicines Consortium have given the green light to Novartis/Avexis’ costly gene therapy, Zolgensma.

Morning in Jebel Shams, Oman
NHS England 'moved mountains' to strike Zolgensma deal • Source: Shutterstock

More from Europe

More from Geography